menu ☰
menu ˟

MM-398 plus chemotherapy extended OS, PFS in metastatic pancreatic cancer

03 Jul 2014
The addition of the novel agent MM-398 to chemotherapy with 5-fluorouracil and leucovorin significantly extended OS and PFS among patients with metastatic pancreatic cancer, according to study results presented at the ESMO World Congress on Gastroint...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.